GIORGI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 28.657
AS - Asia 14.741
EU - Europa 11.658
SA - Sud America 2.979
OC - Oceania 492
AF - Africa 418
Continente sconosciuto - Info sul continente non disponibili 18
Totale 58.963
Nazione #
US - Stati Uniti d'America 27.347
SG - Singapore 4.113
CN - Cina 3.755
IT - Italia 3.131
HK - Hong Kong 2.772
BR - Brasile 2.189
GB - Regno Unito 1.347
VN - Vietnam 1.204
PL - Polonia 1.043
SE - Svezia 1.000
BG - Bulgaria 935
CA - Canada 928
DE - Germania 741
TR - Turchia 657
FR - Francia 578
RU - Federazione Russa 547
IN - India 503
FI - Finlandia 484
UA - Ucraina 422
AU - Australia 413
JP - Giappone 348
KR - Corea 331
CL - Cile 267
MX - Messico 244
CH - Svizzera 238
NL - Olanda 233
ES - Italia 212
AR - Argentina 164
BD - Bangladesh 162
ID - Indonesia 153
CO - Colombia 112
AT - Austria 98
PT - Portogallo 98
IE - Irlanda 97
IQ - Iraq 92
IR - Iran 91
ZA - Sudafrica 88
EC - Ecuador 86
EG - Egitto 84
BE - Belgio 82
GR - Grecia 82
NZ - Nuova Zelanda 79
PK - Pakistan 78
TH - Thailandia 77
TW - Taiwan 65
PE - Perù 55
VE - Venezuela 53
CI - Costa d'Avorio 45
RO - Romania 43
SA - Arabia Saudita 43
CZ - Repubblica Ceca 36
PH - Filippine 36
UZ - Uzbekistan 36
DK - Danimarca 35
HU - Ungheria 35
JO - Giordania 35
MA - Marocco 35
MY - Malesia 35
SN - Senegal 33
CR - Costa Rica 28
DZ - Algeria 26
NP - Nepal 25
LV - Lettonia 24
IL - Israele 23
JM - Giamaica 21
KE - Kenya 21
TN - Tunisia 20
UY - Uruguay 19
NG - Nigeria 18
NO - Norvegia 18
PY - Paraguay 18
AE - Emirati Arabi Uniti 15
KZ - Kazakistan 15
ET - Etiopia 14
PA - Panama 14
BO - Bolivia 13
KH - Cambogia 13
LT - Lituania 13
EU - Europa 12
GT - Guatemala 11
SK - Slovacchia (Repubblica Slovacca) 11
AZ - Azerbaigian 10
BJ - Benin 10
HN - Honduras 10
RS - Serbia 10
BY - Bielorussia 9
OM - Oman 9
TT - Trinidad e Tobago 9
BB - Barbados 8
EE - Estonia 8
MK - Macedonia 8
AL - Albania 7
DO - Repubblica Dominicana 7
HR - Croazia 7
MT - Malta 7
BN - Brunei Darussalam 6
KG - Kirghizistan 6
LY - Libia 6
PR - Porto Rico 6
PS - Palestinian Territory 6
Totale 58.866
Città #
Woodbridge 3.021
Hong Kong 2.733
Ashburn 2.460
Singapore 2.276
Ann Arbor 1.963
Houston 1.816
Fairfield 1.736
Chandler 1.356
San Jose 1.299
Santa Clara 1.023
Dallas 990
Milan 966
Sofia 932
Beijing 854
Seattle 743
Shanghai 733
Wilmington 702
New York 690
Cambridge 624
Jacksonville 596
Ottawa 585
Serra 468
Princeton 467
Boardman 427
Lawrence 379
Izmir 356
Medford 340
Lauterbourg 337
Nanjing 334
Hefei 327
Los Angeles 311
Council Bluffs 281
Tokyo 271
Ho Chi Minh City 270
Redwood City 264
Seoul 252
Des Moines 206
Bern 182
Hanoi 182
Istanbul 174
São Paulo 173
Rome 157
Buffalo 147
Dearborn 141
Redondo Beach 141
Santiago 137
Dong Ket 134
Nanchang 120
London 114
Menlo Park 114
Helsinki 111
San Diego 109
Jüchen 108
Sydney 99
Munich 90
Columbus 86
Boulder 82
Frankfurt am Main 82
Shenyang 82
Falls Church 81
Montréal 71
The Dalles 71
Manchester 70
Vienna 70
Melbourne 67
Rio de Janeiro 66
Kunming 65
Hebei 64
Bogotá 61
Guangzhou 61
Orem 60
Ogden 59
Khulna 58
Changsha 57
San Francisco 56
Ames 55
Mumbai 55
Pune 53
Tianjin 53
Curitiba 52
Atlanta 51
Chennai 50
Pisa 48
Montreal 47
Belo Horizonte 46
Brisbane 46
Cairo 46
Amsterdam 45
Chicago 45
Abidjan 44
Norwalk 44
Jakarta 43
Jiaxing 43
Warsaw 43
Fuzhou 41
Hangzhou 41
Birmingham 40
Bristol 40
Mcallen 40
Utrecht 40
Totale 38.341
Nome #
Trazodone: A review of its pharmacological properties and its off-label use in dogs and cats 3.855
Paracetamol: A Focus on Dogs 1.598
DEVELOPMENT AND VALIDATION OF A NEW HPLC-FLUORIMETRIC METHOD TO DETERMINE EPIRUBICIN AND ITS METABOLITEEPIRUBICINOL IN DOG PLASMA 1.033
ANTINOCICEPTIVE PROPERTIES OF HYDRO ALCOHOLIC EXTRACTS OF ANETHUM GRAVEOLENS L. (DILL) SEED AND AERIAL PARTS IN MICE 452
BIOPHARMACEUTICS OF METOCLOPRAMIDE: INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS AND PER RECTUM ADMINISTRATIONS IN RABBITS 439
PHARMACOKINETICS AND PHARMACODYNAMICS OF ZOLPIDEM AFTER ORAL ADMINISTRATION OF A SINGLE DOSE IN DOGS 383
CJ-023,423 (Grapiprant) a potential novel active compound with antihyperalgetic properties for veterinary patients 343
A BRIEF OVERVIEW OF THE COXIB DRUGS IN THE VETERINARY FIELD 318
Pilot in vivo investigation of cerium oxide nanoparticles as a novel anti-obesity pharmaceutical formulation 291
MIRTAZAPINE IN BEAGLE DOGS 284
EVALUATION OF PLASMA DETECTABLE CONCENTRATIONS OF TWO LIDOCAINE TRANSDERMAL FORMULATIONS AND THEIR ANALGESIC EFFECT IN THE HORSE 274
Novel LC-MS/MS method for CJ-023423 (Grapiprant) determination in rabbit plasma 272
Pharmacokinetics of Bedrocan (marijuana extract oil) in fasted and fed dogs: a pilot study 269
Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment 246
First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study 245
Intoxication of dogs and cats with common stimulating, hallucinogenic and dissociative recreational drugs 242
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients 242
Analytical Method Validation of Vilazodone with Spectrofluorimetric Detection in Rabbit Plasma 238
BLOOD CONCENTRATION OF ENROFLOXACIN AND ITS METABOLITE CIPROFLOXACIN IN YELLOW-BELLIED SLIDER TURTLES (TRACHEMYS SCRIPTA SCRIPTA), AFTER A SINGLE INTRACOELOMIC INJECTION OF ENROFLOXACIN 229
Anticonvulsant activity of hydroalcoholic phoenix dactylifera fruit extract and pimpinella anisum oil in mice 227
A NEW HPLC METHOD FOR THALIDOMIDE DETECTION IN HUMAN PLASMA 225
Pharmacokinetic and pharmacodynamic evaluations of levofloxacin in broiler chickens 220
Natural substances as new potential strategies for the treatment of Leishmaniosisin Dogs 219
Bioanalytical Method Validation and Quantification of Flupirtine in Canine Plasma by HPLC with Spectrofluorimetric Detection 218
USE OF A LASERCYTE® FOR THE COMPLETE BLOOD COUNT IN DOGS WITH ONCOHEMATOLOGICAL DISORDERS 217
PHARMACOKINETIC/PHARMACODYNAMIC ASSESSMENTS OF 10 MG/KG TRAMADOL INTRAMUSCULAR INJECTION IN YELLOW-BELLIED SLIDER TURTLES (TRACHEMYS SCRIPTA SCRIPTA). 216
DEVELOPMENT AND VALIDATION OF A NEW GC-MS METHOD FOR DETECTION OF TRAMADOL, O-DESMETHYLTRAMADOL, 6-ACETYLMORPHINE AND MORPHINE IN BLOOD, BRAIN, LIVER, AND KIDNEY OF WISTAR RATS TREATED WITH THE COMBINATION OF HEROIN AND TRAMADOL 208
PHARMACOKINETIC OF TRAMADOL AND ITS MAJOR CONJUGATES AFTER SINGLE PER OS ADMINISTRATION OF THE SUSTAINED TABLET AND PER RECTUM SUPPOSITORIES FORMULATIONS IN DOGS 204
DEVELOPMENT AND VALIDATION OF A NEW GC-MS METHOD FOR DETECTION OF TRAMADOL, O-DESMETHYLTRAMADOL, 6-ACETYLMORPHINE AND MORPHINE IN BLOOD, BRAIN, LIVER, AND KIDNEY OF WISTAR RATS TREATED WITH THE COMBINATION OF HEROIN AND TRAMADOL 204
INULIN BASED HYDROGEL FOR ORAL DELIVERY OF FLUTAMIDE: PREPARATION, CHARACTERIZATION AND IN VIVO RELEASE STUDIES 199
Gabapentin in Cattle: A Pharmacology Snapshot 197
PILOT IN VIVO TOXICOLOGICAL INVESTIGATION OF BORON NITRIDE NANOTUBES 197
NEW HPLC METHOD TO DETECT INDIVIDUAL OPIOIDS (HEROIN AND TRAMADOL) AND THEIR METABOLITES IN THE BLOOD OF RATS ON COMBINATION TREATMENT 194
Pharmacokinetics of Sulpiride Following Intravenous, Intramuscular and Oral Single Dose Administration in Nurse Mares 190
Effects of liquid and freeze-dried grapefruit juice on the pharmacokinetics of praziquantel and its metabolite 4′-hydroxy praziquantel in beagle dogs 186
COMPARISON OF INJECTABLE PARECOXIB VERSUS ROBENACOXIB FOR PERI-OPERATIVE USE IN DOGS: PRELIMINARY RESULTS 186
Pharmacokinetic/pharmacodynamic evaluation of grapiprant in a carrageenan-induced inflammatory pain model in the rabbit 185
Pharmacokinetics of Metoclopramide After IntraARTERIAL, Intramuscular, Subcutaneous, and Perrectal Administration in Rabbits 184
Pharmacokinetics of Bedrocan®, a cannabis oil extract, in fasting and fed dogs: An explorative study 184
Dispositions of enrofloxacin and its major metabolite ciprofloxacin in Thai swamp buffaloes 183
PHARMACOKINETICS OF METHYLPHENIDATE AFTER ORAL ADMINISTRATION OF IMMEDIATE AND SUSTAINED RELEASE PREPARATIONS IN BEAGLE DOGS 181
Validation of an HPLC-FL method for the determination of tepoxalin and its major metabolite in horse plasma 181
BIOCOMPATIBILITY OF BORON NITRIDE NANOTUBES: AN UP-DATE OF IN VIVO TOXICOLOGICAL INVESTIGATION 181
hCG is more effective than the GnRH agonist buserelin for inducing the first ovulation of the breeding season in mares 180
ABNORMAL FINDINGS IN HAEMOGRAMS OF DACHSHUND PUPPIES: PRESUMPTIVE (IMMUNODEFICIENCY) FAMILIAL DISEASE 179
PHARMACOKINETIC INVESTIGATIONS OF THE MARKER ACTIVE METABOLITE-4-METHYLAMINO-ANTIPYRIN AFTER INTRAVENOUS AND INTRAMUSCULAR INJECTION OF METAMIZOLE IN HEALTHY SHEEP 179
Simultaneous detection and quantification of parecoxib and valdecoxib in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology. 177
A BRIEF OVERVIEW OF OUR CURRENT UNDERSTANDING OF NIVALENOL: A GROWING POTENTIAL DANGER YET TO BE FULLY INVESTIGATED 177
Ex vivo antibacterial activity of levofloxacin against Escherichia coli and its pharmacokinetic profile following intravenous and oral administrations in broilers 177
Pharmacokinetics of levosulpiride after single-dose administration by different routes in sheep (Ovis aries Linnaeus) 177
CLINICAL INTERACTION BETWEEN GRAPEFRUIT-JUICE AND CYCLOSPORINE: IS THERE ANY INTEREST FOR VETERINARY MEDICINE? 176
GLI ANALGESICI IN MEDICINA VETERINARIA. Animali da compagnia (oppioidi, a2 agonisti e ketamina) 176
PHARMACOKINETICS OF METHYLPHENIDATE FOLLOWING TWO ORAL FORMULATIONS (IMMEDIATE AND SUSTAINED RELEASE) IN THE DOG 176
A comparative kinetic study of thiamphenicol in pre-ruminant lambs and calves 176
QUANTIFICATION OF TAPENTADOL IN CANINE PLASMA BY HPLC WITH SPECTROFLUORIMETRIC DETECTION: DEVELOPMENT AND VALIDATION OF A NEW METHODOLOGY 176
PHARMACOKINETIC PROFILES OF THE NOVEL COX-2 SELECTIVE INHIBITOR CIMICOXIB IN DOGS 174
Analgesici oppiodi: HPLC-FL e LC-UV-ESI-MS/MS per la determinazione simultanea del tramadolo e dei suoi metaboliti nel plasma di cavallo 174
Pharmacokinetics of meloxicam in lactating goats (Capra hircus) and its quantification in milk after a single intravenous and intramuscular injection 174
EVALUATION OF TRAMADOL AND ITS MAIN METABOLITES IN HORSES PLASMA BY HPLC-FL AND LC-ESI-MS/MS TECHNIQUES 173
Pharmacokinetics and disposition of flupirtine in the horse 173
Levofloxacin in veterinary medicine: a literature review 173
PHARMACOKINETCIS STUDY OF CLAZURIL (APPERTEX®) IN EGGS AND PLASMA FROM LAYING HENS AFTER SINGLE AND MULTIPLE TREATMENT BY A NEW HPLC METHOD 172
ANIMAL POISONING FREQUENCY IN CENTRAL ITALY (YEARS 2003-2004) 171
Pharmacokinetic and pharmacodynamic evaluations of a 10 mg/kg enrofloxacin intramuscular administration in bearded dragons (Pogona vitticeps): A preliminary assessment 171
CLINICAL AND HEMATOLOGICAL ADVERSE EFFECTS AFTER ADMINISTRATION OF TWO DIFFERENT CHEMOTHERAPY PROTOCOLS IN DOGS AFFECTED BY LYMPHOMA 170
DETECTION AND QUANTIFICATION OF CIMICOXIB, A NOVEL COX-2 INHIBITOR, IN CANINE PLASMA BY HPLC WITH SPECTROFLUORIMETRIC DETECTION: DEVELOPMENT AND VALIDATION OF A NEW METHODOLOGY 168
Role of Natural Products in Ameliorating Drugs and Chemicals Toxicity 168
Pharmacokinetics and estimated bioavailability of grapiprant, a novel selective prostaglandin E2 receptor antagonist, after oral administration in fasted and fed dogs 168
BIOGENIC AMINE CONTENT IN “PECORINO DEL PARCO DI MIGLIARINO - SAN ROSSORE” 167
ORAL ADMINISTRATION OF TEPOXALIN IN THE HORSE: A PK/PD STUDY 167
Cardiovascular effects and intraoperative pharmacokinetics of tramadol in sheep undergoing spinal surgery 167
Pharmacokinetic Assessment of the Marker Active Metabolites 4-Methyl-amino-antipyrine and 4-Acetyl-amino-antipyrine After Intravenous and Intramuscular Injection of Metamizole (Dipyrone) in Healthy Donkeys 166
Effect of feeding on the pharmacokinetics of vilazodone in dogs 166
Cebranopadol, a novel first-in-class drug candidate: Method validation and first exploratory pharmacokinetic study in rabbits 166
A NEW HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF IOHEXOL AND p-AMINOHIPPURIC ACID IN PLASMA OF DOGS 165
LABORATORY DIAGNOSTIC EXAMINATIONS IN VETERINARY TOXICOLOGY 165
PHARMACOKINETICS OF INTRAVENOUS AND INTRAMUSCULAR PARECOXIB IN HEALTHY BEAGLES 165
PHARMACOKINETICS OF MIRTAZAPINE AND ITS MAIN METABOLITES AFTER SINGLE INTRAVENOUS AND ORAL ADMINISTRATIONS IN RATS AT TWO DOSE RATES 165
Exposure assessment of multiple mycotoxins in black and white sesame seeds consumed in Thailand 165
MIRTAZAPINE IN VETERINARY MEDICINE A PHARMACOLOGICAL RATIONALE FOR ITS APPLICATION IN CHRONIC PAIN 164
PHARMACOKINETICS OF MIRTAZAPINE AND ITS MAIN METABOLITES AFTER SINGLE ORAL ADMINISTRATION IN FASTING/FED HORSES 164
DETECTION AND QUANTIFICATION OF THE SELECTIVE EP4 RECEPTOR ANTAGONIST CJ-023423 (GRAPIPRANT) IN CANINE PLASMA BY HPLC WITH SPECTROFLUORIMETRIC DETECTION 164
A new HPLC method to determine glomerular filtration rate and effective renal plasma flow in conscious dogs by single intravenous administration of iohexol and p-aminohippuric acid 163
Impact of low-dose ozone supplementation on motility parameters and bacterial growth in horse cryopreserved semen 163
Pharmacokinetics of levosulpiride after single-dose administration in goats (Capra hircus) by different routes of administration 162
ASSESSMENT OF THE PHARMACOKINETIC PROFILE OF TRAMADOL AND ITS MAIN METABOLITES IN PLASMA AND URINE FORM DOGS ORALLY ADMINISTERED WITH CONTRAMAL®, WITH OR WITHOUT FREEZE-DRIED GRAPE-FRUIT JUICE 161
PHARMACOKINETICS OF THE NOVEL ATYPICAL OPIOID TAPENTADOL FOLLOWING ORAL AND INTRAVENOUS ADMINISTRATION IN DOGS 161
Effects of liquid and freeze-dried grapefruit juice on the pharmacokinetics of praziquantel and its metabolite 4 '-hydroxy praziquantel in beagle dogs 161
IN SITU FORMING GEL LIKE DEPOT OF A POLYASPARTAMIDE-POLYLACTIDE COPOLYMER FOR ONCE A WEEK ADMINISTRATION OF SULPIRIDE 161
Determination of tramadol and metabolites by HPLC-FL and HPLC-MS/MS in urine of dogs 161
CONSTRUCTION AND EVALUATION OF SPONGE SCAFFOLDS FROM HYALURONIC ACID DERIVATIVES FOR POTENTIAL CARTILAGE REGENERATION 160
HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC DETERMINATION OF THALIDOMIDE IN PATIENTS AFFECTED BY HEPATOCELLULAR CARCINOMA 159
PHARMACOKINETIC EVALUATION OF TRAMADOL AND ITS MAJOR METABOLITES AFTER SINGLE ORAL SUSTAINED TABLET ADMINISTRATION IN THE DOG: A PILOT STUDY 159
Apoptosis and gene expression in Jurkat human T cells and lymphoid tissues of fusarenon-X-treated mice 158
The role of clomipramine in potentiating the teratogenic effects of caffeine in pregnant rats: a histopathological study 157
THE PHARMACOKINETICS AND IN VITRO/EX VIVO CYCLOOXYGENASE SELECTIVITY OF PARECOXIB AND ITS ACTIVE METABOLITE VALDECOXIB IN CATS 157
PHARMACOKINETIC PROFILES OF THE ANALGESIC DRUG FLUPIRTINE IN CATS 157
EU PERSPECTIVES OF BIOEQUIVALENCE TEST FOR THE APPROVAL OF GENERIC VETERINARY MEDICINAL PRODUCTS. THE ROLE OF EXCIPIENTS 156
CHARACTERIZATION OF IN VIVO PLASMA METABOLITES OF TEPOXALIN IN HORSES USING LC-MS-MS 156
Clinical studies of metronomic chemotherapy in dogs 156
Totale 25.578
Categoria #
all - tutte 158.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.917


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.397 149 304 155 303 720 604 134 251 215 160 268 1.134
2022/20233.898 548 364 298 385 513 565 88 295 564 34 188 56
2023/20246.088 622 547 526 402 668 782 218 328 136 1.089 309 461
2024/202511.967 135 546 186 644 871 972 1.012 900 1.434 1.832 1.361 2.074
2025/202613.359 678 1.580 1.488 1.228 1.028 1.321 1.797 781 959 1.335 640 524
2026/2027716 716 0 0 0 0 0 0 0 0 0 0 0
Totale 59.942